NEUROCRINE BIOSCIENCES INC Annual Costs and Expenses in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Neurocrine Biosciences Inc quarterly/annual Costs and Expenses history and growth rate from 2020 to 2023.
  • Neurocrine Biosciences Inc Costs and Expenses for the quarter ending June 30, 2024 was $445M, a 17.3% increase year-over-year.
  • Neurocrine Biosciences Inc Costs and Expenses for the twelve months ending June 30, 2024 was $1.58B, a 4% increase year-over-year.
  • Neurocrine Biosciences Inc annual Costs and Expenses for 2023 was $1.64B, a 32% increase from 2022.
  • Neurocrine Biosciences Inc annual Costs and Expenses for 2022 was $1.24B, a 20.2% increase from 2021.
  • Neurocrine Biosciences Inc annual Costs and Expenses for 2021 was $1.03B, a 16.8% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.64B +$397M +32% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-09
2022 $1.24B +$209M +20.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-09
2021 $1.03B +$148M +16.8% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-09
2020 $883M Jan 1, 2020 Dec 31, 2020 10-K 2023-02-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.